LENZ Therapeutics, Inc
8 clinical trials · Sponsor
◉ Watch LENZ Therapeutics, Inc
| Record | Firm | Date |
|---|---|---|
| Plasma Pharmacokinetics and Safety of LNZ101 and LNZ100 Ophthalmic Solutions in Healthy Adult Subjects With Presbyopia (NCT05936489) | LENZ Therapeutics, Inc | 2023-07-06 |
| Phase 3 Efficacy Study of LNZ100 & LNZ101 for the Treatment of Presbyopia (NCT05728944) | LENZ Therapeutics, Inc | 2023-03-06 |
| Phase 3 Safety Study of LNZ100 and LNZ101 for the Treatment of Presbyopia Subjects (NCT05753189) | LENZ Therapeutics, Inc | 2023-02-21 |
| Phase 3 Evaluation of the Safety and Efficacy of LNZ100 & LNZ101 for the Treatment of Presbyopia (NCT05656027) | LENZ Therapeutics, Inc | 2022-12-19 |
| Evaluation of the Safety and Effectiveness of Aceclidine (LNZ101) and Aceclidine + Brimonidine (LNZ100) in the Treatment of Presbyopia (NCT05431543) | LENZ Therapeutics, Inc | 2022-08-06 |
| Evaluation of the Safety and Effectiveness of Aceclidine/Brimonidine (LNZ101) and Aceclidine (LNZ100) in the Treatment of Presbyopia (NCT05294328) | LENZ Therapeutics, Inc | 2022-05-05 |
Track LENZ Therapeutics, Inc automatically
Every clearance here is in the API, with alerts when new ones post.